Mitochondrial dysfunction in Parkinson’s disease

Angot E, Steiner JA, Hansen C, Li JY, Brundin P (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9(11):1128–1138. https://doi.org/10.1016/S1474-4422(10)70213-1

Article  PubMed  Google Scholar 

Arai T, Fukae J, Hatano T, Kubo S, Ohtsubo T, Nakabeppu Y, Mori H, Mizuno Y, Hattori N (2006) Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson’s disease. Acta Neuropathol 112(2):139–145. https://doi.org/10.1007/s00401-006-0081-9

Article  CAS  PubMed  Google Scholar 

Auluck PK, Caraveo G, Lindquist S (2010) alpha-Synuclein: membrane interactions and toxicity in Parkinson’s disease. Annu Rev Cell Dev Biol 26:211–233. https://doi.org/10.1146/annurev.cellbio.042308.113313

Article  CAS  PubMed  Google Scholar 

Barodia SK, McMeekin LJ, Creed RB, Quinones EK, Cowell RM, Goldberg MS (2019) PINK1 phosphorylates ubiquitin predominantly in astrocytes. NPJ Parkinsons Dis 5:29. https://doi.org/10.1038/s41531-019-0101-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515–517. https://doi.org/10.1038/ng1769

Article  CAS  PubMed  Google Scholar 

Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM (1989) Mitochondrial function in Parkinson’s disease. Lancet 2(8653):49. https://doi.org/10.1016/s0140-6736(89)90291-2

Article  CAS  PubMed  Google Scholar 

Bui M, Gilady SY, Fitzsimmons RE, Benson MD, Lynes EM, Gesson K, Alto NM, Strack S, Scott JD, Simmen T (2010) Rab32 modulates apoptosis onset and mitochondria-associated membrane (MAM) properties. J Biol Chem 285(41):31590–31602. https://doi.org/10.1074/jbc.M110.101584

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010) Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486(3):235–239. https://doi.org/10.1016/j.neulet.2010.09.061

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, Kuum M, Zharkovsky A, Kaasik A (2011) Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 286(12):10814–10824. https://doi.org/10.1074/jbc.M110.132514

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciarlo L, Manganelli V, Garofalo T, Matarrese P, Tinari A, Misasi R, Malorni W, Sorice M (2010) Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ 17(6):1047–1058. https://doi.org/10.1038/cdd.2009.208

Article  CAS  PubMed  Google Scholar 

Cole NB, Dieuliis D, Leo P, Mitchell DC, Nussbaum RL (2008) Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res 314(10):2076–2089. https://doi.org/10.1016/j.yexcr.2008.03.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cossu D, Yokoyama K, Sato S, Noda S, Sechi LA, Hattori N (2021) PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 359:577694. https://doi.org/10.1016/j.jneuroim.2021.577694

Article  CAS  PubMed  Google Scholar 

Csordas G, Hajnoczky G (2009) SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta 1787(11):1352–1362. https://doi.org/10.1016/j.bbabio.2009.06.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, Balla T, Mannella CA, Hajnoczky G (2006) Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 174(7):915–921. https://doi.org/10.1083/jcb.200604016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305(5688):1292–1295. https://doi.org/10.1126/science.1101738

Article  CAS  PubMed  Google Scholar 

Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99(22):14524–14529. https://doi.org/10.1073/pnas.172514599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273(16):9443–9449. https://doi.org/10.1074/jbc.273.16.9443

Article  CAS  PubMed  Google Scholar 

Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283(14):9089–9100. https://doi.org/10.1074/jbc.M710012200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Monte D, Jewell SA, Ekstrom G, Sandy MS, Smith MT (1986) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes. Biochem Biophys Res Commun 137(1):310–315. https://doi.org/10.1016/0006-291x(86)91211-8

Article  PubMed  Google Scholar 

Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A, Hoffer B, Cullheim S, Mohammed AH, Olson L, Larsson NG (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A 104(4):1325–1330. https://doi.org/10.1073/pnas.0605208103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307(4):1061–1073. https://doi.org/10.1006/jmbi.2001.4538

Article  CAS  PubMed  Google Scholar 

Esteves AR, Arduino DM, Swerdlow RH, Oliveira CR, Cardoso SM (2010) Microtubule depolymerization potentiates alpha-synuclein oligomerization. Front Aging Neurosci 1:5. https://doi.org/10.3389/neuro.24.005.2009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faustini G, Bono F, Valerio A, Pizzi M, Spano P, Bellucci A (2017) Mitochondria and alpha-synuclein: friends or foes in the pathogenesis of Parkinson’s disease? Genes (Basel). https://doi.org/10.3390/genes8120377

Article  PubMed  Google Scholar 

Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 24(30):6715–6723. https://doi.org/10.1523/JNEUROSCI.1594-04.2004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK (2011) ER tubules mark sites of mitochondrial division. Science 334(6054):358–362. https://doi.org/10.1126/science.1207385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fukae J, Takanashi M, Kubo S, Nishioka K, Nakabeppu Y, Mori H, Mizuno Y, Hattori N (2005) Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson’s disease and related neurodegenerative disorders. Acta Neuropathol 109(3):256–262. https://doi.org/10.1007/s00401-004-0937-9

Article 

留言 (0)

沒有登入
gif